Eric Burak
2022
In 2022, Eric Burak earned a total compensation of $1.4M as Chief Technology Officer at Fusion Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,710 |
|---|---|
| Option Awards | $778,463 |
| Salary | $459,403 |
| Other | $16,927 |
| Total | $1,416,503 |
Burak received $778.5K in option awards, accounting for 55% of the total pay in 2022.
Burak also received $161.7K in non-equity incentive plan, $459.4K in salary and $16.9K in other compensation.
Rankings
In 2022, Eric Burak's compensation ranked 2,346th out of 5,683 executives tracked by ExecPay. In other words, Burak earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,346 out of 5,683 | 59th |
Division Manufacturing | 1,275 out of 3,091 | 59th |
Major group Chemicals And Allied Products | 569 out of 1,406 | 60th |
Industry group Drugs | 524 out of 1,307 | 60th |
Industry Biological Products, Except Diagnostic Substances | 130 out of 295 | 56th |
Source: SEC filing on April 27, 2023.
Burak's colleagues
We found two more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2022.